PHARMACOKINETIC STUDY OF FLUDARABINE PHOSPHATE (NSC-312887)

被引：73

作者：

HERSH, MR

KUHN, JG

PHILLIPS, JL

CLARK, G

LUDDEN, TM

VONHOFF, DD

机构：

[1] UNIV TEXAS,HLTH SCI CTR,DEPT MED,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284

[2] UNIV TEXAS,HLTH SCI CTR,SCH PHARM,SAN ANTONIO,TX 78284

[3] AUDIE L MURPHY MEM VET HOSP,SAN ANTONIO,TX 78284

[4] CANC THERAPY & RES CTR,SAN ANTONIO,TX 78284

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 17卷 / 03期

关键词：

D O I：

10.1007/BF00256699

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：277 / 280

页数：4

共 12 条

[1] 2-FLUORO-ATP - A TOXIC METABOLITE OF "9-BETA-D-ARABINOSYL-2-FLUOROADENINE [J].

AVRAMIS, VI ;

PLUNKETT, W .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 113 (01) :35-43

[2] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[3]

BROCKMAN RW, 1980, CANCER RES, V40, P3610

[4] BIOLOGIC ACTIVITY OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE - METABOLICALLY STABLE ANALOG OF 9-BETA-D-ARABINOFURANOSYLADENINE [J].

BROCKMAN, RW ;

SCHABEL, FM ;

MONTGOMERY, JA .

BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) :2193-2196

[5]

HUTTON JJ, 1984, CANCER RES, V44, P4183

[6]

Jusko WJ, 1980, APPLIED PHARMACOKINE, P639

[7]

MALSPEIS L, 1984, INVEST NEW DRUG, V2, P116

[8]

Metzler C.M., 1976, USERS MANUAL NONLIN

[9]

NOKER PE, 1983, CANCER TREAT REP, V67, P445

[10]

PLUNKETT W, 1980, CANCER RES, V40, P2349

← 1 2 →